ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,181, issued on Sept. 22, was assigned to Lucie Carrier (Hamburg, Germany).
"Gene-therapy vectors for treating cardiomyopathy" was invented by Lucie Carrier (Hamburg, Germany), Thomas Eschenhagen (Hamburg, Germany), Thomas Voit (London), Giulia Mearini (Hamburg, Germany), Oliver Mueller (Dossenheim, Germany), Doreen Stimpel (Hamburg, Germany) and Julia Mourot-Filiatre (Brazilia, Brazil).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a gene therapy vector which is useful in the treatment or prevention of hypertrophic cardiomyopathy in a subject in need thereof. The gene therapy vector of the invention comprises a nucle...